Neither Vitamin C nor E Associated With Reduced Risk of Prostate Cancer or Other Cancers
Boston, MA - In a major cancer prevention study, researchers at Brigham and Women’s Hospital (BWH) found that long-term supplementation with vitamin E or C did not reduce the risk of prostate or other cancers for nearly 15,000 middle-aged and older male physicians. This study will be published online on December 9, and in the January 7 issue of the Journal of the American Medical Association.
In some observational studies, intake or blood levels of vitamins E and C have been associated with reduced risk of certain cancers. However, “Definitive proof that vitamins E and C can reduce the risk of overall or site-specific cancers must rely on large-scale randomized trials,” said J. Michael Gaziano, MD, MPH, Chief of the Division of Aging at BWH. “A number of trials have addressed the potential role of vitamins in the prevention of cancer; however, the results from these trials have not been consistent.”
The researchers conducted the Physicians’ Health Study II, a randomized, placebo-controlled trial to examine the effects of vitamin E and vitamin C on prostate cancer and total cancer. The study included 14,641 male physicians in the United States, age 50 years or older at the time of entering the trial, of whom 1,307 had a prior history of cancer. Participants were randomized to receive individual supplements of 400 IU of vitamin E every other day and 500 mg of vitamin C daily.
During an average follow-up of 8 years, there were 1,943 confirmed total cancer cases and 1,008 prostate cancer cases. Compared with placebo, vitamin E had no effect on the incidence of prostate cancer or total cancer. The researchers also found no significant effect of vitamin C on total cancer or prostate cancer. Neither vitamin E nor vitamin C had a significant effect on site-specific cancers, including colorectal, lung, bladder and pancreatic. Stratification by various cancer risk factors demonstrated no significant modification of the effect of vitamin E on prostate cancer risk or either agent on total cancer risk.
Despite uncertainty about the long-term health effects or benefits, more than half of US adults take vitamin supplements, and vitamins E and C are among the most popular individual supplements. “These data provide no support for the use of vitamin E and C supplements in the prevention of cancer in middle-aged and older men,” the authors conclude.
The research was funded by grants from the National Institutes of Health and an investigator-initiated grant from BASF Corporation.
Brigham and Women's Hospital (BWH) is a 777-bed nonprofit teaching affiliate of Harvard Medical School and a founding member of Partners HealthCare, an integrated health care delivery network. In July of 2008, the hospital opened the Carl J. and Ruth Shapiro Cardiovascular Center, the most advanced center of its kind. BWH is committed to excellence in patient care with expertise in virtually every specialty of medicine and surgery. The BWH medical preeminence dates back to 1832, and today that rich history in clinical care is coupled with its national leadership in quality improvement and patient safety initiatives and its dedication to educating and training the next generation of health care professionals. Through investigation and discovery conducted at its Biomedical Research Institute (BRI), BWH is an international leader in basic, clinical and translational research on human diseases, involving more than 860 physician-investigators and renowned biomedical scientists and faculty supported by more than $416 M in funding. BWH is also home to major landmark epidemiologic population studies, including the Nurses' and Physicians' Health Studies and the Women's Health Initiative. For more information about BWH, please visit www.brighamandwomens.org.
Send
Feedback to: 
